first bancorp

YRC Worldwide, Inc. (Nasdaq: YRCW) 23.8% LOWER; pulling back today after a more than 130 percent move last week into this week.

The volume on today's move is already better than three-times average. First BanCorp. (NYSE: FBP) 23.2% HIGHER; entered into a definitive agreement with two funds managed by Oaktree Capital Management, L.P. under which Oaktree would purchase an aggregate of approximately $175.5 million of common stock of the Corporation at a per share price of $3.50.

First BanCorp (NYSE: FBP) 78.3% HIGHER; announced today that it has signed an agreement with the United States Department of the Treasury pursuant to which it will issue a new series of preferred stock in exchange for the preferred stock the U.S.

Treasury currently holds. Click here to see the full report. Broadway Financial Corp. (Nasdaq: BYFC) 51.4% HIGHER; reported Q1 EPS of $0.39, versus $0.29 reported for the same period a year ago.

Icagen, Inc. (Nasdaq: ICGN) 39.6% HIGHER; today reported positive results in its Phase IIa epilepsy study of ICA-105665, the Company's novel orally available small molecule KCNQ potassium channel agonist. Click here to see the full report.

Xfone (NYSE: XFN) 28% HIGHER; the stock is continuing higher today following a 15% jump yesterday.

Dynavax Technologies Corporation (NASDAQ: DVAX) 28.1% HIGHER; announced today that its GMP manufacturing facility in Dusseldorf, Germany has been approved for the commercial production of hepatitis B surface antigen, a key component of HEPLISAV, the Company's investigational adult hepatitis B vaccine.

The approval comes as a result of an upgrade expanding production capacity. With an updated European Union GMP manufacturing license in place, Dynavax can meet the initial commercial production demands for the anticipated launch of HEPLISAV.